Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Conclusion: The use of rvWF and rVIII resulted in adequate hemostasis peripartum. Further prospective data are required to reaffirm the safety and dosing of rvWF for peripartum management of patients with vWD who require intervention.DisclosuresKazi: Shire: Other: Vonvendi was provided by Shire.

Source: Blood - November 21, 2018 Category: Hematology Authors: Kazi, S., Malinowski, A. K., Whitehead, C., Kuo, K. H. M., Harrington, L., Watts, N., Wang, C., Shehata, N. Tags: 401. Basic Science and Clinical Practice in Blood Transfusion Source Type: research